Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2019; 08(04): 225-240
DOI: 10.4103/sajc.sajc_132_19
Letter to the Editor

Tamoxifen and fulvestrant induced steatohepatitis with cirrhosis: A rare case report

Somnath Roy
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Jaya Ghosh
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Nitin Shetty
Department of Radiodiagnosis, Tata Memorial Hospital, Mumbai, Maharashtra
,
Munita Bal Menon
Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Anant Ramaswamy
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
,
Sudeep Gupta
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
14 December 2020

© 2019. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Dziamski KM, Kalakonda A, Kohlitz P. A rare case of fulvestrant-associated jaundice and hepatotoxicity. Am J Ther 2019;26:e122-3.
  • 2 Oien KA, Moffat D, Curry GW, Dickson J, Habeshaw T, Mills PR, et al. Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet 1999;353:36-7.
  • 3 Storen EC, Hay JE, Kaur J, Zahasky K, Hartmann L. Tamoxifen-induced submassive hepatic necrosis. Cancer J 2000;6:58-60.